ARA-C associated pulmonary toxicity.
نویسندگان
چکیده
منابع مشابه
Drug-induced pulmonary disease: an update.
The review provides an update of drug-induced pulmonary disorders, focusing on newer agents whose effects on the lung have been studied recently. Included among these drugs are cyclosporine, cytosine arabinoside (Ara-C), amiodarone, interleukin-2 (IL-2), OKT3, tricyclic antidepressants, and bromocriptine. A brief review of the most common cytotoxic and noncytotoxic agents causing pulmonary toxi...
متن کاملFatal cardiac toxicity in two patients receiving same-day administration of cyclophosphamide and cytarabine as conditioning for hematopoietic stem cell transplantation.
The dose-limiting factor of cyclophosphamide (CPA) is cardiac toxicity.1 The maximum tolerated dose of CPA is approximately 200 mg/kg and fatal cardiac toxicity is rare at lower doses.1 However, two groups reported that same-day administration of cytarabine (Ara-C) and CPA increased the incidence of fatal cardiac toxicity.2,3 On the other hand, in the BEAC regimen, one of the most popular prepa...
متن کاملA longitudinal study of anti-RNA polymerase III antibody levels in systemic sclerosis.
OBJECTIVES Anti-RNA-polymerase antibodies (ARAs) are associated with the diffuse cutaneous subset of SSc (dcSSc) and particularly with scleroderma renal crisis (SRC). We analysed serial ARA levels and explored the relationship with clinical features and disease outcome. METHODS A commercially available ELISA method with a recombinant peptide of RNA polymerase III was used and ARA levels were ...
متن کاملEnhancement of the toxicity and DNA incorporation of arabinosyl-5-azacytosine and 1-beta-D-arabinofuranosylcytosine by cyclopentenyl cytosine.
We evaluated the interaction of a biochemically active concentration of cyclopentenyl cytosine (CPE-C), an investigational antimetabolite which inhibits CTP synthetase, on the cytotoxicity of arabinosyl-5-azacytosine (Ara-AC) and 1-beta-D-arabinofuranosylcytosine (Ara-C) in HCT 116 colon carcinoma cells. A 3-h exposure to 0.5 microM CPE-C depleted CTP pools by over 90% and decreased dCTP pools ...
متن کاملCladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study.
An international phase 2 study combining cladribine and cytarabine (Ara-C) was initiated for patients with refractory, risk-organ-positive Langerhans cell histiocytosis (LCH) in 2005. The protocol, comprising at least two 5-day courses of Ara-C (1 g/m(2) per day) plus cladribine (9 mg/m(2) per day) followed by maintenance therapy, was administered to 27 patients (median age at diagnosis, 0.7 ye...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Turkish journal of haematology : official journal of Turkish Society of Haematology
دوره 28 1 شماره
صفحات -
تاریخ انتشار 2011